Ranbaxy Laboratories Limited- Strategy and SWOT Report
MarketLine, September 2011, Pages: 50
Ranbaxy Laboratories Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Ranbaxy Laboratories Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ranbaxy Laboratories Limited in the form of a SWOT analysis
- An in-depth view of the business model of Ranbaxy Laboratories Limited including a breakdown and examination of key business segments
- Intelligence on Ranbaxy Laboratories Limited’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ranbaxy Laboratories Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Ranbaxy Laboratories (Ranbaxy), a subsidiary of Daiichi Sankyo, is the largest generic pharmaceutical company in India. It is engaged in the manufacture and trade of formulations, active pharmaceuticals ingredients (API) and intermediates, generics, drug discovery and consumer health care products. It also focuses on research and development activities primarily in India. The company operates in India, Europe, North America and Asia Pacific. It is headquartered in Gurgaon, India and employed 13,420 people as of December 31, 2010. The company recorded revenues of INR89,607.7 million ($1,953.4 million*) during the financial year (FY) ended December 2010, an increase of 18% over FY2009. The operating profit of the company was INR29,363.8 million ($640.1 million) during FY2010, as compared to an operating profit of INR13,484.2 million ($294 million*) in 2009. The net profit was INR14,967.5 million ($326.3 million*) in FY2010, as compared to a net profit of INR2,964.9 million ($64.6 million*) in FY2009. * Calculated using the constant currency conversion rate of INR1 = $0.0218 for the financial year ended December 31, 2010.
Reasons to Purchase:
- Gain understanding of Ranbaxy Laboratories Limited and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Ranbaxy Laboratories Limited as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Ranbaxy Laboratories Limited’s business structure, strategy and prospects
Company Snapshot
Ranbaxy Laboratories Limited: Company Overview
Ranbaxy Laboratories Limited: Overview and Key Facts
Ranbaxy Laboratories Limited: Overview
Ranbaxy Laboratories Limited: Key Facts
Ranbaxy Laboratories Limited: Key Employees
Ranbaxy Laboratories Limited: Key Employee Biographies
Ranbaxy Laboratories Limited: Major Products and Services
Ranbaxy Laboratories Limited: Company History
Ranbaxy Laboratories Limited: Management Statement
Ranbaxy Laboratories Limited: Locations and Subsidiaries
Ranbaxy Laboratories Limited: Key Competitors Ranbaxy Laboratories Limited: Company Analysis
Ranbaxy Laboratories Limited: Business Description
Ranbaxy Laboratories Limited: SWOT Analysis
Ranbaxy Laboratories Limited: SWOT Overview
Ranbaxy Laboratories Limited: Strengths
Ranbaxy Laboratories Limited: Weaknesses
Ranbaxy Laboratories Limited: Opportunities
Ranbaxy Laboratories Limited: Threats
Ranbaxy Laboratories Limited: Corporate Financial Deals Activity
Ranbaxy Laboratories Limited: Financial Deals Overview
Ranbaxy Laboratories Limited: Targets and Partners
Ranbaxy Laboratories Limited: Top Deals 2007 -YTD-2012
Ranbaxy Laboratories Limited: Advisors
Ranbaxy Laboratories Limited: Top Legal Advisors
Ranbaxy Laboratories Limited: Top Financial Advisors
Ranbaxy Laboratories Limited: Mergers and Acquisitions
Ranbaxy Laboratories Limited: Capital Raising
Ranbaxy Laboratories Limited: Partnership
Ranbaxy Laboratories Limited: Divestments
Ranbaxy Laboratories Limited: Private Equity and Ownership Ranbaxy Laboratories Limited: Recent Developments
Ranbaxy Laboratories Limited: News and Events Summary
Ranbaxy Laboratories Limited: Business Expansion
Ranbaxy Laboratories Limited: Business Reorganization
Ranbaxy Laboratories Limited: Contracts
Ranbaxy Laboratories Limited: Corporate Governance
Ranbaxy Laboratories Limited: Financial Deals
Ranbaxy Laboratories Limited: Financial Performance
Ranbaxy Laboratories Limited: Regulatory and Legal Events
Ranbaxy Laboratories Limited: Strategy and Operations Appendix
Contact Us
Methodology
Definitions
About Datamonitor List of Tables Table 1: Ranbaxy Laboratories Limited: Key Facts Table 2: Ranbaxy Laboratories Limited: Key Employees Table 4: Ranbaxy Laboratories Limited: Key Competitors Table 5: Ranbaxy Laboratories Limited: Deal Activity by Deal Type - Volume (TTM-) Table 6: Ranbaxy Laboratories Limited: M&A Activity by Geography (TTM-) Table 7: Ranbaxy Laboratories Limited: Deal Activity by Deal Type - Volume (2008 - YTD-2012) Table 8: Ranbaxy Laboratories Limited: M&A Average Deal Size - Value (US$m) Table 9: Ranbaxy Laboratories Limited: Targets and Partners Table 10: Ranbaxy Laboratories Limited: Top Deals 2007 -YTD-2012 Table 11: Ranbaxy Laboratories Limited: Legal Advisor Ranking by Value (US$m) Table 12: Ranbaxy Laboratories Limited: Financial Advisor Ranking by Value (US$m) Table 13: Ranbaxy Laboratories Limited: M&A Volume and Value Trend (2008 - YTD-2012) Table 14: Ranbaxy Laboratories Limited: M&A Activity by Geography (2008 - YTD-2012) Table 15: Ranbaxy Laboratories Limited: Capital Raising Volume and Value Trend (2008 - YTD-2012) Table 16: Ranbaxy Laboratories Limited: Capital Raising by Deal Type (2008 - YTD-2012) Table 17: Ranbaxy Laboratories Limited: Partnership Volume and Value Trend (2008 - YTD-2012) Table 18: Ranbaxy Laboratories Limited: Partnership Trend by Deal Type (2008 - YTD-2012) Table 19: Ranbaxy Laboratories Limited: Divestments Volume and Value Trend (2008 - YTD-2012) Table 20: Ranbaxy Laboratories Limited: Divestments by Geography (2008 - YTD-2012) Table 21: Ranbaxy Laboratories Limited: Private Equity and Ownership Volume and Value Trend (2008 - YTD-2012) Table 22: Ranbaxy Laboratories Limited: Private Equ
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
